Primary Job Title President and Chief Executive Officer Primary Organization Sana Biotechnology
Gender Male
Steve Harr, M.D., is the president and CEO of Sana Biotechnology.
He is the former chief financial officer and head of corporate development for Juno Therapeutics; he joined the organization in 2014. Before joining Juno, Dr. Harr was managing director and head of biotechnology investment banking at Morgan Stanley for approximately four years,
with a previous position at the firm as their lead biotech research analyst and co-head of their global healthcare research arm.
Dr. Harr received a B.A. in economics from College of the Holy Cross and an M.D. from the Johns Hopkins University School of Medicine. He was a resident in internal medicine at the University of California, San Francisco.
